High-Volume Scanners

PRODUCTS

  • The Challenge: Building Scalable Viral Vector Programs

    Cell and gene therapies offer unprecedented hope for previously untreatable diseases. At the heart of many of these advanced therapies, including both gene therapies and gene-modified cell therapies, are viral vectors, particularly Adeno-Associated Vectors (AAV) and Lentiviral Vectors (LVV), which serve as crucial gene-delivery vehicles.

  • Scientific knowledge to strategize viable and efficient drug and device development pathways to achieve successful outcomes.

  • Expediting the customer journey from discovery all the way through commercial release.

  • Addressing Modern mAb Purification Challenges

    The latest protein A resin from Purolite, an Ecolab company, DurA Cycle A50 aims to maximize productivity and improve process economics.

    DurA Cycle A50 improves purification performance with high capacities, which can help to enable a lower cost per gram of commercial drug product. Building on the innovation of Praesto™ Jetted A50 HipH, DurA Cycle A50 provides a wider elution pH window to address aggregate clearance.

  • Help your patients make informed decisions without burying them in paper

    With electronic informed consent (eConsent) software, your patients can access consent forms using any device they choose. And because it’s part of TrialKit’s unified platform, both your patients and your study team get a seamless experience.

WHITE PAPERS AND CASE STUDIES

NEWS